Literature DB >> 12848014

[Inhaled corticosteroids in idiopathic pulmonary hemosiderosis: 2 cases].

Nabil Ben Halima1, Abderrahmen Karray, Anas Krichen, Hichem Feki, Mounir Ben Salah, Imène Chabchoub, Mongia Hachicha, Abdelmajid Mahfoudh, Ali Triki.   

Abstract

Idiopathic pulmonary hemosiderosis, a rare clinical entity, is characterized by bleeding into the alveoli and progressive pulmonary fibrosis. It is usually treated with systemic corticosteriod during acute bleeding episodes and with prolonged courses of oral corticosteroids and/or other immunosuppressant drugs for maintenance therapy. Because prolonged treatment with these agents is frequently associated with significant side effects, favorable response to inhaled corticosteroids would be ideal in this condition. The authors reports 2 cases of idiopathic pulmonary hemosiderosis diagnoses in the pediatric department of Sfax: a 20 month old boy and an 8 year old girl successfully treated with inhaled beclomethazone dipropionate using doses of 500_g/day and low dose oral prednisolone (0.5 mg/kg one day/2).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12848014

Source DB:  PubMed          Journal:  Tunis Med        ISSN: 0041-4131


  1 in total

1.  Use of Corticosteroids in the management of Idiopathic Pulmonary Haemosiderosis: Do we have enough evidence.

Authors:  Ammara Mushtaq; Subika Khatoon; Muhammad Asif Qureshi
Journal:  Pak J Med Sci       Date:  2015 Mar-Apr       Impact factor: 1.088

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.